0 Yorumlar
0 hisse senetleri
556 Views
0 önizleme
Sponsorluk
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Canine Stem Cell Therapy Market Outlook: 4.0% CAGR Growth Through 2031According to a newly published market research report by 24LifeSciences, global canine stem cell therapy market was valued at USD 60 million in 2024 and is projected to reach USD 78.5 million by 2031, growing at a compound annual growth rate (CAGR) of 4.0% during the forecast period 20252031. Canine stem cell therapy utilizes a dog's own regenerative cells to treat orthopedic conditions...0 Yorumlar 0 hisse senetleri 583 Views 0 önizleme
-
Global Musculoskeletal Stem Cell Therapy Market Showing 9.2% CAGR Through 2034According to a new report from Intel Market Research, the global Musculoskeletal Disorder Stem Cell Therapy market was valued at USD 1.45 billion in 2025 and is projected to reach USD 3.28 billion by 2034, growing at a notable CAGR of 9.2% during the forecast period (2026–2034). This expansion reflects the growing clinical adoption of regenerative medicine solutions for orthopedic...0 Yorumlar 0 hisse senetleri 817 Views 0 önizleme
-
Global stem cell therapy for diabetes market outlook with 9.7% CAGR growth (2025–2031)According to a newly published market research report by 24LifeSciences, global stem cell therapy for diabetes and related conditions market was valued at USD 456 million in 2024 and is projected to reach USD 892 million by 2031, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 2025–2031. Stem cell therapy...0 Yorumlar 0 hisse senetleri 681 Views 0 önizleme
-
Stem Cell Therapy Market Size to Surpass US$ 8.9 Billion by 2031Stem cell therapy plays a crucial role in regenerative medicine by promoting healing at the cellular level. Instead of masking symptoms, it aims to address the root cause of tissue damage through biological repair mechanisms. Market Overview The Stem Cell Therapy Market is projected to grow from US$ 3.5 billion in 2023 to US$ 8.9 billion by 2031, registering a CAGR of 8.7% during the forecast...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Aesthetic Exosomes Market to 2031: In-Depth Analysis, Emerging Opportunities, and Future Growth PotentialThe Aesthetic Exosomes Market is rapidly evolving as a key innovation in the global medical aesthetics and regenerative medicine industry. Exosomes are nano-sized extracellular vesicles composed of proteins, lipids, and nucleic acids that enable cellular communication and tissue regeneration. Their growing use in aesthetic applications such as skin rejuvenation, anti-aging therapies, and...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Global Dynamics and Regional Insights: Aesthetic Exosomes Market to 2031 – Size, Share and ForecastThe Aesthetic Exosomes Market is rapidly gaining prominence as a transformative segment in aesthetic medicine and regenerative skincare, driven by a growing preference for minimally invasive treatments and advanced cellular therapies. Exosomes — nano-sized extracellular vesicles that carry proteins, lipids, and genetic material — are increasingly used to stimulate collagen...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Global Tissue Engineering Market by 2028 – Market Report Scope and Industry AnalysisThe Global Tissue Engineering Market is experiencing rapid growth as advancements in regenerative medicine, biomaterials, and stem cell research continue to transform modern healthcare. Tissue engineering involves the development of biological substitutes that restore, maintain, or improve tissue function, making it a critical solution for organ failure, chronic diseases, and traumatic...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
Sponsorluk
Sponsorluk